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It is suggested to use ‘enzyme(s)-erythrocyte-antibody’ complex for modulation of the microenvironment 
in definite compartments of blood circulation. A model system including peroxidase, human erythrocytes 
and anti-collagen antibodies was chosen to illustrate the principle. Peroxidase was conjugated to the ery- 
throcyte surface via periodate-oxidized enzyme carbohydrate moiety; biotinylated antibodies were linked 
by avidin to the biotinylated erythrocytes. The properties of the tmmunocomplexes obtained have been in- 
vestigated in an artificial system simulating an injured blood vessel wall. The advantages in using erythro- 
cyte-mediated immunoenzyme complexes for enzyme (drug) targeting are discussed. 
Drug targeting Collagen Immobilized enzyme 
1. INTRODUCTION 
The targeting of drugs included in synthetic 
(liposomes) or natural (erythrocytes) containers 
possessing high specific affinity for organ, tissue 
or cell target, can be an effective method in treat- 
ment of many diseases [l-5]. High local concentra- 
tion of the drug in the focus of the pathological 
process is the main advantage of targeting. In re- 
cent years significant success in the improvement 
of targeted intracellular injection of drugs has been 
achieved [6-81. However, in some diseases (e.g., 
mural thrombogenesis [9]), the desired locus of 
drug action may be exposed to the bloodstream. 
There are three main obstacles to the practical ap- 
plication of systems employing water-soluble drug 
delivery from targeted containers - liposomes or 
erythrocytes in these cases. First, drug release from 
the container needs to be associated with its fixa- 
tion on the target surface. Second, a considerable 
portion of the drug released into the blood will be 
washed off by the bloodstream before it can dif- 
fuse into the target tissue. Third, a container can 
discharge only once and, therefore, cannot induce 
prolonged effects. 
Antibody attachment Perouidase Specific binding 
Another approach would be the continuous con- 
version of inactive drug precursor(s) circulating in 
the blood into an active form by the targeted en- 
zyme(s). A number of enzymes have been suc- 
cessfully introduced into clinical practice to correct 
metabolic disorders. Co-immobilization of both 
enzymes and antibodies on a biodegradable carrier 
is expected to be advantageous over direct immu- 
noenzyme conjugates in the following respects: 
(i) Enzyme stability can be improved as a result 
of immobilization [ 10,l I]. 
(ii) Several different enzymes can operate in con- 
cert performing sequential transformation of 
metabolite. 
(iii) Cooperative interaction of antibodies can 
provide tight specific binding at much lower an- 
tibody to enzyme ratios. Cooperative interaction 
of monoclonal antibodies with different specifici- 
ties can be realized. 
We have shown previously that red blood cells 
conjugated with antibodies to human type I col- 
lagen selectively bind to denuded regions of a 
human artery ex vivo [5]. This work explores the 
possibility of concurrent antibody and enzyme im- 
mobilization on the erythrocyte surface and in- 
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vestigates the properties of the complex obtained 
for enzyme targeting in vitro. 
2. MATERIALS AND METHODS 
The blood from healthy volunteers was collected 
into acid-citrate anticoagulant and kept at 4°C for 
not more than 3 days. Before use the erythrocytes 
were 5 times washed by centrifugation in phos- 
phate-buffered saline (PBS) (138 mM NaCl, 2.7 
mM KCl, 8.1 mM Na2HP04, 1.5 mM KH2P04, 
pH 7.4). 
Type I collagen was obtained from human 
placenta, and rabbit anticollagen antibodies were 
obtained according to [12]. Avidin from hen egg- 
white was isolated according to 1131 and assayed 
spectrophotometrically as in [ 14]. Bovine serum 
albumin (BSA) (Sigma), horseradish peroxidase 
(HRP) (Fluka), and biotin ~-hydroxysuccinimide 
ester (Sigma) were used in the study. 
2.1. HRP immobilization on erythrocyte surface 
The standard procedure was as follows: 25 ~1 
freshly prepared aqueous NaI04 (40 mg/ml) was 
added to 100 pl aqueous HRP (10 mglml). After 
25 min incubation (20°C) the oxidized HRP 
(ox.HRP) was gel filtered by centrifugation on a 
microcolumn with Sephadex G-25 into buffer (0.15 
M NaCl, 1 mM CHXOONa; pH 3.8). The washed 
erythrocytes were placed in buffer (100 mM NaCl, 
50 mM Na2CO3; pH 9.3) and 100~1 of gel-filtered 
ox.HRP was added to 100 ~41 of erythrocyte 
suspension (hematocrit value 50%, v/v). After 2 h 
incubation at 20°C with constant vigorous agita- 
tion, 30~1 NaBH4 (15 mg/ml in PBS) was added, 
incubated for 15 min under vortex-mixing, then 
erythrocytes were washed by centrifugation using 
6 x 10 ml PBS. ‘251-labeled HRP was added to the 
initial HRP solution as a tracer to determine the 
amount of immobilized protein. 
2.2. Assay of immobilized HRP activity 
HRP substrate was prepared by dissolving 1 mg 
o-phenylenediamine in 0.1 ml methanol and mix- 
ing it with 5 ~1 30% Hz02 in 10 ml PBS. 
0.1 ml of HRP-carrying or intact erythrocyte 
suspension (hematocrit 0.5%) in PBS-BSA (PBS, 
containing 2 mg/mI BSA) was mixed with an equal 
volume of substrate solution in a well of a Micro- 
test microtitration plate (Dynatex). After 10 min 
incubation the plates were centrifuged in a TH-4 
rotor (Beckman) at 3000 rpm for 2 min. Then, 100 
~1 of supernatant from each well was quickly 
transferred to the corresponding well of the empty 
plate, 25 ~1 of 50% H2S04 were added to each well 
and 10 min later the absorbance in the wells at 490 
nm was determined with an MR-580 Autoreader 
spectrophotometer (Dynatex). The obtained data 
were compared with the calibration curve obtained 
in identical conditions using known amounts of 
HRP dissolved in PBS-BSA. 
2.3. Coupling of antibodies to erythrocyte surface 
and erythrocyte incubation in antigen-coated 
wells 
The procedure was carried out as described in 
[4]. Briefly, the antibodies or non-immune rabbit 
IgG and erythrocytes (intact or HRP-carryin8~ 
were biotinylated separately. Then the excess of 
biotin ester was removed and avidin and biotiny- 
lated protein were added to biotin-modified eryth- 
rocytes. To determine the amount of the coupled 
protein, ‘251-labeled IgG was added to the initial 
IgG solution as a tracer. 
Multiwell plates (Falcon) were coated with type 
I collagen or BSA as in [4]. The non-bound excess 
of antigen was preincubated with PBS-BSA for 1 
h. Then 300 ~1 of erythrocyte suspension 
(hematocrit 0.5%) were added to the wells and in- 
cubation and washing of non-bound erythrocytes 
were performed as in [4]. Each sample of 
erythrocytes was incubated in two identical wells. 
2.4. Quantitation of antigen-bound erythrocytes 
and associated peroxidase activity 
After washing, a standard volume of distilled 
water was added to a well, and hemoglobin absor- 
bance at 405 nm in lysate was determined. The 
amount of erythrocytes in the well was estimated 
according to the calibration curve obtained with 
standard erythrocyte suspension lysates. 
An identical well was washed out and sup- 
plemented with 500~1 substrate solution, incubated 
for 10 min with careful stirring, then 200~1 sub- 
strate was transferred to a well of a Microtest (Lin- 
bro) plate, 50~1 of 50% &So4 was added and 10 
min later the absorbance at 490 nm was determined. 
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3. RESULTS AND DISCUSSION 
Enzymes may be immobilized on the erythrocyte 
surface in various ways. HRP conjugation via its 
carbohydrate moiety oxidized by periodate was 
chosen because: (i) this precluded unwanted 
chemical modification of erythrocytes, (ii) this 
method is suitable for conjugation with immuno- 
globulins [ 161, (iii) it seemed to be adaptable for 
various carbohydrate-containing enzymes. For ex- 
ample, galactose oxidase was effectively linked to 
polymers in a similar manner [ 151. Fig. I demon- 
strates a linear dependence of HRP coupling to 
erythrocytes on initial ox.HRP concentration in 
the reaction mixture. It reaches lo5 molecules of 
bound HRP per erythrocyte at the highest ox.HRP 
concentration used (5 mg/ml). The loss of bound 
HRP activity was attributed mainly to the oxida- 
tion step and did not exceed 25% of the initial ac- 
tivity (fig.2). In subsequent experiments it was 
possible to evaluate the number of immobilized 
HRP molecules according to its activity associated 
with erythrocytes. 
The efficiency of coupling was strictly depen- 
dent on the degree of oxidation of HRP car- 
bohydrate residues; non-oxidized HRP did not 
bind to erythrocyte membrane. It is seen from fig.3 
that the coupling value reaches a plateau at a 
periodate/HRP molar ratio equal to 200, and fur- 
ther increase in periodate concentration had little 
V 1 
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Fig.1. Dependence of HRP coupling to erythrocytes on 
ox.HRP concentration in reaction medium (after sub- 
traction of the background of inherent erythrocyte 
peroxidase activity equal to the activity of 8 x IO3 WRP 
molecules per erythrocyte). Incubation time 2 h; 
periodate/HRP molar ratio = 200. 
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Fig.2. The effect of oxidation on HRP activity at dif- 
ferent periodate/HRP molar ratios. 
effect. Evidently, at a molar ratio equal to 200 the 
majority of the reactive carbohydrate groups of 
the enzyme are oxidized. At this molar ratio fur- 
ther experiments were performed. It was necessary 
to remove thoroughly periodate after HRP oxida- 
tion, since periodate caused significant hemolysis. 
Fig.4 shows the time course of the coupling reac- 
tion. The reaction rate was constant over 6 h, and 
much lower than that of HRP coupling to im- 
munoglobulins 1161. Further increase of incuba- 
tion time was of no use because of hemolysis. In 
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Fig.3. Dependence of HRP coupling to erythrocytes on 
the degree of HRP oxidation (periodate/HRP molar 
ratio). incubation time 2 h, ox.HRP concentration in the 
reaction medium 3.5 mg/ml. 
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INCUBATiON TIME. 
hours 
Fig.4. The kinetics of HRP couphng to erythrocytes. 
Conditions are described in section 2. 
biotin ester reacted with amino groups. The 
amount of amino groups (or any other reactive 
groups) on the erythrocyte surface is limited, as 
well as the space accessible for protein conjuga- 
tion. To optimize enzyme loading, it was necessary 
to determine the minimal quantity of antibodies 
sufficient to provide specific targeting. In previous 
experiments 4.5 x 10’ antibody moiecules per cell 
were successfully used. Fig.5 shows that equally ef- 
fective attachment of immunoerythrocytes to 
antigen-coated surface could be achieved at 3 x 1 O4 
molecules per cell. Lowering of the ratio to 1 x lo4 
molecules per cell caused only a 2-fold decrease in 
IO4 molecules/ RBC 
Fig.% Dependence of antibody-erythrocyte complex 
binding to collagen-coated surface on the number of 
antibody molecules immobilized on erythrocyte. 
attachment. It is worth mentioning, however, that 
this value will differ for various antibody prepara- 
tions; so we have estimated an order of magnitude. 
Up to lo6 enzyme molecules can be conjugated to 
the erythrocyte surface and antibody would not be 
a limitation. Using ‘251-labeled IgG, we compared 
the efficiency of immunogiobulin attachment via 
avidin-biotin interaction to intact and HRP- 
carrying er~hroc~es. It was found that HRP im- 
mobilization did not effect the subsequent linkage 
of antibodies. In turn, the procedure of HRP- 
carrying erythrocyte biotinylation and subsequent 
antibody attachment did not influence the activity 
of immobilized NRP. 
Finahy, we studied binding of peroxidase- 
erythrocyte antibody complexes to the colagen- 
coated surfaces. A system simtdating denuded 
blood vessel wall has been described [3]. Peroxi- 
dase-conjugated immunoerythrocytes differ from 
- 
2 3 4 
Fig.& Binding of immunoerythro~ytes to coifagen- 
coated surface. (A) Number of erythrocytes bound per 
cm’ surface. (B) WRP activity bound per cm2 surface 
(HRP activity after incubation of samples 2 and 4 was 
negligible), expressed as the number of peroxidase 
molecules. (1) HRP-antibody-erythrocyte, (2) HRP- 
non-immune IgG-erythrocyte, (3) antibody-erythrocyte, 
(4) non-immune-IgG~rythrocyte. 
65 
Volume 182, number 1 FEBS LETTERS 
enzyme-free counterparts neither in efficiency nor 
in specificity of binding to the corresponding col- 
lagen type (fig.6) (binding of erythrocytes to BSA- 
coated surfaces was less than lo4 per cm2). Sub- 
stantial peroxidase activity was retained only in the 
collagen-coated wells incubated with peroxidase- 
erythrocytes carrying antibodies with respective 
specificity. An increased background level in the 
case of enzyme-free immunoerythrocytes was at- 







The results obtained illustrate the efficiency of 
enzyme-erythrocyte-antibody complexes in specific 
targeting and manifestation of enzymatic activity. 
With a choice of proper enzyme(s) this system may 
be practically used for prevention of mural throm- 
bosis or for targeted thrombolysis. More com- 
plicated systems employing combination of both 
enzyme and drug targeting are now being designed. 
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